Insights

Expansion Opportunity Cytotheryx is rapidly expanding its real estate footprint in Rochester, MN, with multiple facility acquisitions totaling 7.6 million dollars and plans to scale GMP manufacturing capacity. This signals demand for site services, facility management, and regional supply chain partnerships.

Hepatocyte Supply As a platform focused on scalable production of primary human hepatocytes and related cell lines, Cytotheryx presents opportunities for contract manufacturing, quality control services, bioprocess consulting, and distribution partnerships to biotech and pharma customers needing reliable liver cells.

Strategic Funding Recent $60M Series A funding and accompanying debt facilities indicate strong capital for growth, open doors for strategic alliances, co-development, and long-term supply agreements with pharma, biotech, and academic customers looking for stable sourcing and joint development opportunities.

Vertical Diversification Product line expansion into Cytocine Primary Porcine Hepatocytes suggests a diversified approach to liver cell models, creating cross-sell opportunities into academic labs and biotech customers exploring alternative models, as well as potential regulatory and validation collaboration needs.

Key Partnerships New client Obgfund and growth financing signals attractiveness to venture-backed firms and incubators; leverage these relationships to position Cytotheryx as a preferred provider for early-stage liver disease programs, including lab-scale to GMP-scale transitions and translational studies.

Similar companies to Cytotheryx, Inc.

Cytotheryx, Inc. Tech Stack

Cytotheryx, Inc. uses 8 technology products and services including Quickbooks Online, WordPress, Shopify, and more. Explore Cytotheryx, Inc.'s tech stack below.

Media & News

Cytotheryx, Inc.'s Email Address Formats

Cytotheryx, Inc. uses at least 2 email formats:
Cytotheryx, Inc. Email FormatsExamplePercentage
First.Last@cytotheryx.comJohn.Doe@cytotheryx.com
85%
Last@cytotheryx.comDoe@cytotheryx.com
15%

Frequently Asked Questions

What is Cytotheryx, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Cytotheryx, Inc.'s official website is cytotheryx.com and has social profiles on LinkedIn.

How much revenue does Cytotheryx, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Cytotheryx, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Cytotheryx, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Cytotheryx, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cytotheryx, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Cytotheryx, Inc. has approximately 16 employees across 1 continents, including North America. Key team members include Director Of Regulatory Affairs And Quality Assurance: B. K. Explore Cytotheryx, Inc.'s employee directory with LeadIQ.

What industry does Cytotheryx, Inc. belong to?

Minus sign iconPlus sign icon
Cytotheryx, Inc. operates in the Biotechnology Research industry.

What technology does Cytotheryx, Inc. use?

Minus sign iconPlus sign icon
Cytotheryx, Inc.'s tech stack includes Quickbooks Online, WordPress, Shopify, Microsoft 365, Barracuda Email Protection, Elementor, WP Engine and Box.

What is Cytotheryx, Inc.'s email format?

Minus sign iconPlus sign icon
Cytotheryx, Inc.'s email format typically follows the pattern of First.Last@cytotheryx.com. Find more Cytotheryx, Inc. email formats with LeadIQ.

How much funding has Cytotheryx, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Cytotheryx, Inc. has raised $60M in funding. The last funding round occurred on Jan 12, 2026.

When was Cytotheryx, Inc. founded?

Minus sign iconPlus sign icon
Cytotheryx, Inc. was founded in 2019.
Cytotheryx, Inc. logo

Cytotheryx, Inc.

Biotechnology ResearchMinnesota, United States11-50 Employees

Cytotheryx, Inc. is a biotechnology research company focused on delivering a reliable source of primary human hepatocytes, the functional cells of the liver. Based in Rochester, Minnesota, the firm aims to increase the supply of PHH for use by pharmaceutical and biotechnology companies as well as academic research institutions. Primary human hepatocytes are widely used in research, but limited availability has constrained ongoing work. 

The company operates in the biotechnology research field by pursuing scalable production of liver cells to support liver-disease research and the development of new therapies. In 2026, Cytotheryx expanded its footprint through facility acquisitions and expansions across multiple regions, signaling growth in capacity and geographic reach. In January 2026, the company announced a new client relationship, highlighting demand for its hepatocyte platform.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $60M

    Cytotheryx, Inc. has raised a total of $60M of funding over 2 rounds. Their latest funding round was raised on Jan 12, 2026 as a Debt Financing.

  • $10M - $25M

    Cytotheryx, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.